Navigation Links
SynergEyes, Inc. Expands Launch of New Hybrid Contact Lens Design for Keratoconus Patients
Date:9/4/2009

CARLSBAD, Calif., Sept. 4 /PRNewswire/ -- SynergEyes, Inc., the high Dk hybrid contact lens manufacturer, recently introduced a new advanced lens design for keratoconus patients. ClearKone(TM) is a revolutionary contact lens that takes advantage of the best features of the hybrid platform, providing superior visual acuity, centration, stability, and all-day comfort. The patent-pending design is optimized to vault the predominant irregularities of the keratoconic cornea, thus effectively restoring vision to a vast majority of irregular cornea patients, without compromising comfort or eye health, even in the most challenging cases. ClearKone(TM) is now available in the United States, Canada and Puerto Rico.

SynergEyes lenses are the only FDA-cleared hybrid contact lenses specifically designed for keratoconus vision correction. The SynergEyes(R) KC lens was introduced in 2006, and many keratoconus patients are successfully wearing this design. However, SynergEyes(R) KC is most successful on central, nipple cones, which represent only a portion of the total number of keratoconus cases.

"SynergEyes recognized the need to develop a hybrid contact lens design that could fit a much broader spectrum of keratoconus patients, including oval cones, highly advanced central cones, decentered cones and depending on the specifics of the case, globus keratoconus and pellucid marginal degeneration," says Kellie Kaseburg, Vice President of Global Marketing for SynergEyes. "The ClearKone(TM) lens does just that and will allow many more keratoconus patients to experience the benefits of hybrid technology."

The ClearKone(TM) lens utilizes revolutionary hybrid technology to give keratoconus patients the very best technology has to offer - the excellent visual clarity of a high-oxygen rigid gas permeable contact lens and the all-day comfort and convenience of a soft lens. What makes the ClearKone(TM) lens different from other SynergEyes lenses is the design of the lens itself and the technique used to fit it.

"The ClearKone(TM) hybrid contact lens gives keratoconus patients wearing RGP lenses or a piggyback system a new way to have clearer, more stable vision and better comfort," says Dr. Morris Sheffer of Charlotte, North Carolina. "The design of ClearKone(TM) enables the lens to center very well on irregularly shaped corneas, to provide crisper vision than any other contact lens we have tried. Since the lens is designed to 'vault' over the peak of the cornea, the comfort is also greatly improved. Our patients love the improvement in comfort and vision they get with ClearKone(TM)!"

ClearKone(TM) is currently being prescribed in a number of locations in the United States, Canada and Puerto Rico. Keratoconus patients can visithttp://www.SharingOneVision.com to locate a ClearKone(TM) practitioner.

Incorporating patented HyperBond(TM) technology and HydrolEyes(TM) surface science, the SynergEyes(R) contact lenses with FDA market clearance include: SynergEyes(R) A for naturally occurring ametropia, targeting patients with astigmatism, current gas permeable lens wearers, and patients demanding optimized vision; the SynergEyes(R) Multifocal lens for presbyopia; SynergEyes(R) KC and ClearKone(TM) for keratoconus; and the SynergEyes(R) PS for post-surgery and post-trauma refractive errors.

    Contact:

    Kellie Kaseburg
    Vice President, Global Marketing
    877.SEE.2012

This release was issued through eReleases(TM). For more information, visit http://www.ereleases.com.


'/>"/>
SOURCE SynergEyes, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Related medicine news :

1. SynergEyes, Inc. Launches New Hybrid Lens Design for Keratoconus Patients
2. Misonix Restructures and Expands Sales Organization in Europe
3. United Concordia Dental Expands Benefit Options
4. Misonix Expands Sales Organization for Direct Sales of the SonicOne(TM) Wound Management System and the SonaStar(R) Ultrasonic Surgical Aspirator in the United States
5. Transcend Medical Expands Leadership Team Appointing Chief Medical Officer and Vice President of Clinical Affairs
6. Health Robotics Expands CytoCare(TM) Global Presence With National Taiwan University Hospital and Pinnaclemed
7. Adamas Pharmaceuticals Expands Management Team; Names Michael D. Coffee and Amy K. Patick to Executive Positions
8. Moszkito(R) Expands its Archy(TM) Footwear Collection to Include Closed-Toed Shoes for Fall 2009
9. Health Media Network Expands to New Markets
10. CareTech Expands Services to Garden City Hospital With Radiology Workflow Technology
11. Light Sciences Oncology Expands Development of Novel Targeted Drug Aptocine(TM) For Prostate Conditions With Start-Up of Phase 2 BPH Trial
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:2/26/2017)... ... February 26, 2017 , ... NuevaCare, a leading home care agency ... Belmont, and Palo Alto, is proud to announce an important upgrade to its geographic ... for home care close to home, and by having city-specific pages, NuevaCare is answering ...
(Date:2/26/2017)... ... February 26, 2017 , ... IndustryArchive.Org . is announcing a ... Marketing. B2B Sellers will now only pay for B.A.N.T. quality sales leads based on ... IndustryArchive.Org, said, “Given the new reality that B2B buyers are controlling the sales process ...
(Date:2/26/2017)... ... February 26, 2017 , ... ODH, Inc.™ announced today ... 27-28 at the Sheraton Pentagon City Hotel in Arlington, VA. ODH’s director of medical ... behavioral health analytics to improve Medicaid population health management. , ODH will also have ...
(Date:2/26/2017)... ... February 26, 2017 , ... ... (PD) in persons with a specific LRRK2 mutation, according to a study released ... studies have provided evidence of a link between pesticides and incidence of sporadic ...
(Date:2/24/2017)... ... February 24, 2017 , ... ... TaskMate Go. Core benefits and advantages built into the home office sit stand ... look and feel. Ability to gain the benefits embedded in the TaskMate Go ...
Breaking Medicine News(10 mins):
(Date:2/24/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Urinary Incontinence Drugs ... benchmarks in the global Urinary Incontinence market. The research answers ... key drugs marketed for Urinary Incontinence and their clinical attributes? How ...
(Date:2/23/2017)... Feb. 23, 2017  Cogentix Medical, Inc. (NASDAQ: CGNT), ... innovative proprietary products for the urology market, will release ... ended December 31, 2016 before the market open on ... will host a conference call and webcast to discuss ... 9, 2017 at 11:00 a.m. Eastern Time (10:00 a.m. ...
(Date:2/23/2017)... 2017 Research and Markets has announced the ... - 2016" report to their offering. ... The latest research Oesophageal Cancer Drugs ... benchmarks in the global Oesophageal Cancer market. The research ... the key drugs marketed for Oesophageal Cancer and their clinical attributes? ...
Breaking Medicine Technology: